Ancient Material Promises To Solve Drug Delivery “Pain”
Vaxess is a venture capital and Gates Foundation-backed company that is developing vaccine patches. Their mission is to significantly increase access to vaccines — instead of vaccines having to be shipped in cold storage and administered via a shot, these patches can be shipped in the mail and used from the comfort of people's homes. In order to accomplish this mission, the company is developing novel vaccine formulations and delivery technologies based on its proprietary silk platform.
To learn more about how the team at Vaxess managed to utilize the knowledge about silk to improve the area of drug development, we sat down with Michael Schrader, CEO and co-founder of the biotech.
Topics: Tools & Methods
